FDA Approves Fixed-Dose Prostate Cancer Combination Treatment

[MEDPAGE TODAY]( Oncology Update Tuesday, August 15, 2023 [FDA Approves Fixed-Dose Prostate Cancer Combination Treatment]( [Higher BMI = Less Neutropenia With CDK4/6 Inhibitor for Early Breast Cancer]( [New Bispecific Antibody Nabs Conditional FDA Approval for Myeloma]( [Study Links 'Forever Chemicals' to Testicular Cancer in Military Personnel]( ADVERTISEMENT Exclusives & Features [A 'Few Bad Apple' Docs Spread COVID Misinformation on Social Media]( [AI Beat Clinicians at Figuring Out Difficult Diagnoses]( [Does Kratom Need Tighter Regulation?]( [Complications of Thyroid Cancer Surgery in Pediatric Patients at a Tertiary Cancer Center.]( BACKGROUND: The incidence of complications and risk factors for hypocalcemia after pediatric thyroid cancer surgery has not been clearly defined in the literature because most reports fail to... [READ MORE]( [Two-thirds of cancer waiting time targets to be axed in England]( NHS England want to reduce nine targets to three in a bid to simplify "outdated" standards. [READ MORE]( [Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature]( Background: In urothelial carcinoma (UC), apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) enzymes are major contributors to the mutational burden. The APOBEC family mutates... [READ MORE]( [Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.]( INTRODUCTION: Although daratumumab-containing regimens improve multiple myeloma (MM) outcomes, recurrence is inevitable.METHODS AND OBJECTIVE: We performed a retrospective study using the Canadian... [READ MORE]( [External validation of biochemical recurrence definition to predict oncologic outcomes following focal therapy for localized prostate cancer using high intensity focused ultrasound.]( PURPOSE: This is an external validation of several biochemical recurrence definitions based on prostate specific antigen criteria (PSA). The purpose is to predict the need of additional treatment and... [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-08-15&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011